Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

When Bayer Healthcare launched its new style birth control pills Yasmin and Yaz in 2001 and 2006, respectively, the drugs were marketed under the guise that they were safer than other oral contraceptives. Formulated with a synthetic hormone and containing a diuretic, drospirenone, the pills were touted as having an added benefit of clearing up problem acne and easing the symptoms of premenstrual dysphoric disorder (PMDD). But the honeymoon has ended for Bayer, which is now facing more than a thousand lawsuits from women who said they were not adequately warned that the pills could cause serious and life-threatening health problems such as blood clots and gallbladder problems.

Read the rest of this entry »

The Judicial Panel on Multidistrict Litigation in Washington D.C. has chosen the U.S. District Court in the Southern District of Illinois in East St. Louis to handle multidistrict litigation for what could be as many as 25,000 Yaz lawsuits. Chief Judge David Herndon will preside over the pre-trial proceedings, which have been filed by plaintiffs in all parts of the country against Bayer, the manufacturer of the popular oral contraceptive.

Read the rest of this entry »

Attorneys representing women who have been seriously harmed by Yaz expect that the number of lawsuits against Bayer will escalate dramatically in the coming years, possibly involving thousands of plaintiffs. A 41-year-old writer from Bethesda, Maryland, who is one of the most recent plaintiffs to file a lawsuit against Bayer, recently described her experience taking the drug to the Washington Times.

Read the rest of this entry »